OB/GYN Clinical Alert – September 1, 2024

September 1, 2024

• A Tubal Sterilization Knowledge and Decision Aid Support Tool: Does it Make a Difference?

  A patient-centered decision aid that improves tubal sterilization knowledge and decision-making quality may be able to fill gaps in counseling and supplement the existing Medicaid sterilization consent process.

  Read more

• The Effect of a Full Bladder on Endometrial Biopsy Success in the Office

  In this randomized controlled trial of 214 patients, those with a full bladder prior to Pipelle endometrial biopsy had lower first insertion failure rates without the use of a tenaculum (23.4% vs. 42.1%) compared to those with bladder status not taken into account.

  Read more

• Evaluating the Effectiveness of Treatment Strategies for Managing Cesarean Scar Ectopic Pregnancies

  A review of 460 international cases of cesarean scar pregnancies demonstrated that surgical treatments were extremely effective options, with successful completion in 91.5% (95% confidence interval [CI], 87.8 to 95.2) of suction evacuations and 91.8% (95% CI, 83.8 to 99.9) of surgical excisions compared with a lower success rate for medical options, including local gestational sac injection or systemic methotrexate.

  Read more

• Neurodevelopmental and Psychiatric Risks in Children of Pregnant Mothers Who Use Cannabis

  Although current research has not conclusively established a direct link between prenatal cannabis use and an increased risk of autism spectrum disorder (ASD), psychotic symptoms, anxiety, or depression in offspring, there is evidence suggesting that prenatal cannabis exposure may modestly elevate the risk of attention-deficit/hyperactivity disorder (ADHD). Additionally, children exposed to cannabis in utero may be more likely to use cannabis later in life.

  Read more